EUVIMEDEUVIMED entdecken
Crossref

A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy

Jinqiao Zhang, Ting Tong, Chang Cai, Xianzhou Cai, Bicheng Sun, Kexin Wen, Xinran Qu, Qin Fan, Ziliang Dong iD

ACS Nano · 09.06.2026 · 20 (22) · 16470-16487

DOI: 10.1021/acsnano.6c06363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 28.05.2026. Verfasst von Jinqiao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China. Hauptthemen laut MEDLINE: CD47 Antigen, Radioimmunotherapy, Macrophages, Receptors, Immunologic. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Shandong First Medical University, Natural Science Foundation of Jiangsu Province, Taishan Scholar Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD47 AntigenRadioimmunotherapyMacrophagesReceptors, ImmunologicGenetic EngineeringRadiation-Sensitizing AgentsAnimalsMiceHumansCell Line, TumorFemale

Stichwörter der Autor:innen

CD47-SIRPα axisgenetic engineeringmacrophage nanodecoyphagocytosisradioimmunotherapy

Substanzen

CD47 AntigenReceptors, ImmunologicRadiation-Sensitizing AgentsSirpa protein, mouse

Autor:innen und Institutionen

  • School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China.
  • Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medicine Sciences, Jinan, Shandong 250117, P. R. China.
  • State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, Jiangsu 210000, P. R. China.

ORCID-Profile: Ziliang Dong

Förderung

  • Shandong First Medical University
  • Natural Science Foundation of Jiangsu Province
  • Taishan Scholar Project of Shandong Province
  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Zhang, J., Tong, T., Cai, C., Cai, X., Sun, B., Wen, K., Qu, X., Fan, Q., & Dong, Z. (2026). A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano, 20(22), 16470-16487. https://doi.org/10.1021/acsnano.6c06363

Vancouver

Zhang J, Tong T, Cai C, Cai X, Sun B, Wen K, et al. A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano. 2026;20(22):16470-16487. doi:10.1021/acsnano.6c06363

BibTeX
@article{Zhang2026,
  author = {Zhang, Jinqiao and Tong, Ting and Cai, Chang and Cai, Xianzhou and Sun, Bicheng and Wen, Kexin and Qu, Xinran and Fan, Qin and Dong, Ziliang},
  title = {A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {22},
  pages = {16470--16487},
  doi = {10.1021/acsnano.6c06363}
}
Kostenlos starten →